Mandate

Vinge has advised Santander Consumer Bank AS

March 16, 2020 Banking and Finance

Vinge has advised Santander Consumer Bank AS in connection with its acquisition of all shares in Forso Nordic AB, a subsidiary within the Ford Motor Company group.

Forso Nordic AB is a consumer credit institution who provides financial arrangements for leasing of vehicles in Scandinavia via its branches and subsidiary. The business includes to actively support sales and marketing of Ford Motor Company’s products on the Nordic market and directly or indirectly support the dealer’s sale and marketing of vehicles, spare parts and other vehicle products, by offering financing and administrative services relating thereto.

Vinge’s team consisted of Christina Kokko, Ulrich Ziche, Michaela Cronemyr, Isabelle Jengsell, Hanna Risberg, Clara Sohlberg (M&A), Emma-Stuart Beck, Caroline Krassén, Paulina Malmberg, Elin Samara (Regulatory), Nicklas Thorgerzon (GDPR/IT), Trine Osen Bergqvist, Christina Åqvist (Competition), Sofia Landolsi (Agreements), Ilze Lukins (IPR), Karolina Cohrs (Real Estate), Josefine Lanker (Banking and Finance), Hayaat Ibrahim (CSR), Lisa Ullman (Employment), Viktoria Owetz (VDR Specialist) och Bonnie Holmström (Project Assistant).

Related

Vinge has advised Egetis Therapeutics in connection with a directed share issue

Vinge has advised Egetis Therapeutics AB (publ) (“Egetis Therapeutics”), listed on Nasdaq Stockholm, in connection with a directed share issue whereby Egetis Therapeutics raised proceeds of approximately SEK 183 million before transaction costs.
October 06, 2025

Vinge worked with funds advised by Agilitas on the buy-out of Vivicta (previously Tietoevry Tech Services), including on the issuance of senior secured bonds and on entering into a super senior RCF

Vinge, together with O’Melveny as lead counsel and Avance, worked with funds advised by Agilitas Private Equity LLP (“Agilitas”), the pan-European mid-market private equity firm, in their backing of Vivicta. The buy-out was previously announced on 24 March 2025 and closed on 2 September 2025.
October 03, 2025

Vinge has advised Hansa Biopharma in connection with a directed share issue of approx. SEK 671.5 million

Vinge has advised Hansa Biopharma AB (publ) in connection with a directed share issue through which the company raises proceeds of approx. SEK 671.5 million before transaction costs.
October 03, 2025